search icon
  • What's New in Practice Management & Payment

    CMS Releases 2018 Medicare Physician Fee Schedule Proposed Rule

    CMS: Fact Sheet for the QPP Year 2 Proposed Rule

    AMA Releases New MIPS Resources

    CMS Releases Lookup Tool to Help Clinicians Determine their MIPS Participation Status

    CMS: New Quality Payment Program Resources Available

  • Upcoming Meetings

    IDWeek 2017 logo
    30 July - 4 August, 2017 | Vail, Colorado

    35th Annual Conference on Pediatric Infectious Diseases

    August 10 - 13, 2017 | Stanford, CA

    7th International Coccidioidomycosis Symposium

    August 26 - 30, 2017 | Tysons Corner, VA

    2017 Infectious Disease Board Review Course

  • Find Practice Guidelines

    Also available:

  • Read the Latest from Science Speaks: Global ID News

  • Invalid Feed URL
  • News from IDSA and Journals

    New ATS/IDSA Recommendations for Diagnosis of TB


    Pocketcard Guideline now available for the ATS/IDSA Recommendations on Diagnosis of TB in Adults and Children. Easy to use, summarized version of full guideline. Perfect for quick reference and point-of-care use.

  • Breaking News and Alerts

    7/21/2017 10:41:19 AM

    CDC Investigation Announcement regarding Salmonella Typhimurium infections linked to exposure to clinical and teaching microbiology laboratories

    CDC and public health officials in several states have identified a multistate outbreak of Salmonella Typhimurium infections linked to various clinical, commercial, and college and university teaching microbiology laboratories.

    7/19/2017 12:06:16 PM

    CDC call for cases of NTM following cosmetic surgery in the Dominican Republic

    Several state and local health departments are investigating recent cases of nontuberculous mycobacteria surgical site infections (e.g., Mycobacterium abscessus, Mycobacterium massiliense) associated with cosmetic surgery received in the Dominican Republic.

    7/18/2017 5:01:10 PM

    FDA approves new drug to treat adults with chronic hepatitis C virus genotypes 1-6 without cirrhosis or with mild cirrhosis

    The U.S. Food and Drug Administration today approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis.

    7/10/2017 2:52:14 PM

    Patients Receiving Eculizumab (Soliris®) at High Risk for Invasive Meningococcal Disease Despite Vaccination

    Eculizumab (Soliris®) recipients have a 1,000 to 2,000-fold greater risk of invasive meningococcal disease compared to the general U.S. population. 

    7/10/2017 12:26:19 PM

    IDSA Statement on the Appointment of Dr. Brenda Fitzgerald as Director of CDC

    IDSA Statement on the Appointment of Dr. Brenda Fitzgerald as Director of CDC   The Infectious Diseases Society of America congratulates Dr. Brenda Fitzgerald on her appointment to lead the Centers for Disease Control and Prevention at this critical time.  Strong federal public health leadership will be essen

    7/7/2017 3:18:56 PM

    FDA approves new fluoroquinolone antibiotic to treat bacterial skin infections

    The U.S. Food and Drug Administration today approved Baxdela (delafloxacin), a new antibacterial drug to treat acute bacterial skin and skin structure infections. Baxdela is available for intravenous and oral use.

    7/7/2017 3:27:52 PM

    Ongoing Transmission of Candida auris in Health Care Facilities

    CDC has just released an MMWR update on Candida auris (C. auris) cases identified in U.S. health care facilities through May 2017.

    5/18/2017 1:29:25 PM

    Potential for Falsely Low Blood Lead Test Results from LeadCare® Analyzers

    The U.S. Food and Drug Administration (FDA) has issued a safety communication warning about the use of Magellan Diagnostics’ LeadCare® analyzers (LeadCare, LeadCare II, LeadCare Ultra and LeadCare Plus) with venous blood samples because they might result in falsely low test results. FDA is now advising that Magellan Diagnostics’ LeadCare® analyzers should no longer be used with venous blood samples. The safety alert does not apply to capillary blood lead test results collected by fingerstick or heelstick. The purpose of this Health Advisory is to notify state and local health departments, healthcare providers, and laboratories about CDC’s re-testing guidance in light of the safety alert.

  • Policy News


    IDSA Statement on the House of Representatives State and Foreign Operations and Labor, Health and Human Services FY 2018 funding bills

    IDSA thanks Congressional appropriators for prioritizing many critical public health and research programs, emphasizes need for full funding

| HIVMA | Contact Us

© Copyright IDSA 2017 Infectious Diseases Society of America

Full Site Mobile Site